肿瘤大小、淋巴浸润组无统计学意义。
No differences in tumor size group and lymph node involvement group.
按症状、肿瘤大小和生存期判断疗效。
The therapeutic efficacy was estimated according to changes of symptoms tumor size and survival.
观察肿瘤大小、局部复发和远处转移情况；
The size and shape, local recurrence and remote metastasis of the tumors were observed.
根据肿瘤大小和血供特点确定相应超液化碘油的剂量。
The dose of ultra fluid lipiodol was determined by diameter and blood supply type of HCC.
预后因素与颅神经损害程度、肿瘤大小及病理性质有关。
Progonastic factors related to the damage degree of cranial nerve, tumors' size and pathological nature of the tumors.
阳性脉管数与肿瘤大小、浸润深度和局部淋巴结转移相关；
The number of VEGFR-3 possive vessel is correlated with tumor size infiltration and lymph node metastasis.
影响乳腺癌预后的因素很多，如肿瘤大小，淋巴结转移情况等。
There are some factors that affect the prognosis of the breast carcinoma, for example, size of tumor, status of lymph node, etc.
然而，当t因子更高及肿瘤大小越大，对存活率则是负面影响。
However, survival was negatively affected when the t factor was higher and the tumor size was larger.
的表达与病理组织类型、肿瘤大小、临床分期及淋巴结转移相关。
The expression of VEGF was related to tumor size, clinical stage and status of lymphatic node.
MMP9表达与肿瘤大小、受侵淋巴结数目及临床分期呈正相关。
Positive expression of MMP9 was correlated with tumor size, number of lymph node and clinical stage of breast cancer.
结论小肿瘤中既有腺瘤也有腺癌，肿瘤大小不能作为区分它们的标准。
Conclusion Small renal tumors consist of both adenoma and carcinoma, therefore tumor size can not be used as a criterion in their differential diagnosis.
采用大样本病例队列研究的方法评估了肿瘤大小与转移风险之间的相关性。
We evaluated the association between tumor size and the metastasis risk in a large patient cohort.
听力的保留与肿瘤大小、术前听力水平、肿瘤内听道底侵蚀、小脑损伤相关。
Hearing preservation was correlation to tumor size, preoperative hearing level, internal auditory canal fundus destroying and cerebellum damaging.
肿瘤大小、病理类型以及血清cea水平可能是影响放免显像结果的部分因素。
The size of tumor, pathologic type and serum CEA level may by the factor to affect imaging result.
因而无论肿瘤大小及术前听力状况如何，我们都不能放弃对保留蜗神经的努力。
We can not give up on efforts to retain the cochlear nerve regardless the tumor size and preoperative hearing when ever possible.
原发肿瘤大小、病理组织学类型、腋淋巴结阳性数是影响局部复发的主要因素。
Tumor size, histopathological type, number of positive axillary lymph nodes are the main factors influencing local recurrence.
结论：提示P16蛋白的表达与肝细胞性肝癌的分化程度有关，与肿瘤大小有关。
Conclusion: the expression of P16 protein is related to the degree of the differentiation but not related to the size of the humors.
术前肝功能、术中出血量、肝门阻断时间、肿瘤大小两组间相比较无显著统计学差异。
There was no difference in statistics in hepatic function before operation, volume of bleeding, obstructive time of portal vein and diameter of tumor between two groups.
IR的表达与患者的肿瘤大小、淋巴结转移、临床分期、病理类型、间质反应无相关性。
No significant correlation was observed between expression of IGF-IR and tumor size, lymph node involvement, pathological type, stromal reaction.
并发症的发生率与与喉肿瘤的部位和肿瘤大小有关，还与手术医师、麻醉师的经验有关。
The incidence rate of complications relates to the position and size of the tumors, as well as with the experience of the surgeons and anesthesiologists.
并观察化疗临床症状缓解情况、肿瘤大小的变化、化疗的毒副反应以及术后病理检查情况。
Observed status of clinical symptoms, size of tumor, side effect of chemotherapy and postoperative pathological analysis.
卵巢颗粒细胞瘤的复发率为34.8%，复发与临床病理分期、手术方式及肿瘤大小有关。
The recurrence rate was 34.8%, which was related to the clinical - pathologic stage, primary surgery and tumor size.
他们检查了各种雌激素受体彼此之间的关系怎样以及与肿瘤大小、淋巴结侵袭和转移的关系。
They examined how the various estrogen receptors associated with each other and their relationship with size of the primary breast tumor, lymph node invasion, and development of metastasis.
回顾性研究120例乳腺癌病例的肿瘤大小、淋巴结转移、病理学类型、间质反应、肿瘤分化。
The tumor size, lymph node involvement, pathological type, stromal reaction, tumor differentiation of the 120 breast cancer specimens were reviewed.
在化疗后，用动态ct计算出肿瘤的最大体积，与化疗前肿瘤大小比较，评估局部治疗的效果。
After the therapy, local treatment response was evaluated by dynamic CT calculating the maximum area of the tumor, by comparing it with its size in pre - therapy.
结论：双侧原发性乳腺癌的预后取决于腋窝淋巴结有无转移，肿瘤大小以及ER受体是否阳性。
Conclusions the prognosis of bilateral primary mammary cancer is decided by whether axilla lymph node has transferred, whether the tumor is big or small, and whether the er receptor is positive.
目的：当前的研究证据提示在肾细胞癌病例中，有关肿瘤大小与转移风险之间有明显的差异结果。
Purpose: Recent evidence suggests significantly discordant findings regarding tumor size and the metastasis risk in renal cell carcinoma cases.
联合探讨所有的临床因素，包括结节超声影像、肿瘤大小及细胞学，能够为患者制定最好的决策。
Joint discussions about all clinical factors, including nodule ultrasound imaging, tumor dimensions, and cytology, can be used to determine the best options for patients.
联合探讨所有的临床因素，包括结节超声影像、肿瘤大小及细胞学，能够为患者制定最好的决策。
Joint discussions about all clinical factors, including nodule ultrasound imaging, tumor dimensions, and cytology, can be used to determine the best options for patients.
应用推荐